Ankle And Foot Care Centers Podiatrist Medicare: Not Enrolled in Medicare Practice Location: #1 Fox Lane, Chester, WV 26034 Phone: 330-385-2413 |
News Archive
Early onset drinking, drinking and intoxication at an early age among adolescents, has been identified as a primary risk for later heavy drinking, alcohol problems, and alcohol dependence among youth and young adults. To prevent or delay early onset drinking, we must know more about the modifiable circumstances that enable these behaviors.
BioCryst Pharmaceuticals, Inc. announced preliminary top-line results from its multinational, open-label, single-arm trial evaluating 200 mg once-daily oral forodesine in the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL), as well as interim results from the Company's exploratory Phase 2 study to investigate the efficacy and safety of 200 mg twice-daily oral forodesine as monotherapy for chronic lymphocytic leukemia (CLL).
In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah (formerly known as CTL019) demonstrated long-lasting remissions in non-Hodgkin's lymphoma (NHL) patients.
Inergetics, Inc., a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select from New Marketlink Pharmaceutical Corporation "New Marketlink."
The Wellcome Trust today launches a global funding scheme to seed research into the impact of a changing world on the future of human health.
› Verified 4 days ago